# Notice of Intent to Sole Source: ERVEBO

Canonical: https://abierto.us/opportunities/7160785f397544dc856a314d3c8171a2

- Notice type: Special notice
- Status: Closed. Deadline was July 24, 2024 at 4:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Barda - Aspr / Daappo / Barda DCMA (75A501)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Place of performance: Washington, District of Columbia
- County: District of Columbia (FIPS 11001). https://abierto.us/counties/district-of-columbia-dc-11001
- City: Washington. https://abierto.us/cities/washington-dc-1150000
- First posted: July 9, 2024
- Last posted: July 9, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/7160785f397544dc856a314d3c8171a2/view

## Description

The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Biomedical Advanced Research & Development Authority (BARDA) intends to use other than full and open competition to award a sole source contract to Merck Sharp & Dohme LLC to procure up to 1,000,000 licensed doses of ERVEBO, a vaccine for protection against EBOV, VMI storage of doses, extending expiry of doses, and develop a new manufacturing process using bioreactors.

## Publications

- July 9, 2024: Special notice, due July 24, 2024 at 4:00 PM EDT. Notice 7160785f397544dc856a314d3c8171a2. https://sam.gov/workspace/contract/opp/7160785f397544dc856a314d3c8171a2/view

## Points of contact

- Jonathan Gonzalez, Contracting Officer, Jonathan.Gonzalez@hhs.gov
- Yifan Yang, yifan.yang@hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/7160785f397544dc856a314d3c8171a2.